1-Bromo-4-chloro-2-fluoro-5-methoxy-benzene, 97.0%, 25g

(4R,E)-4-((1R,3aS,7aR,E)-4-((E)-2-((3S,5R)-3,5-bis((tert-butyldimethylsilyl)oxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)-1-cyclopropylpent-2-en-1-ol, 98%, 250mg

1-[(2,2,2-trifluoroethoxy)carbonyl]piperidine-4-carboxylic acid, 95%, 50mg

Barium chloride dihydrate, min. 99%, pa, ACS, ISO, 2.5 kg, plastic packaging.

Phenylhydrazine-4-sulfonamide, 95.0%, 1g

4'-tert-Butyl-2,2,2-trifluoroacetophenone, 97.0%, 1g

Ethyl 6-fluoroimidazo[1,2-a]pyridine-2-carboxylate, 95.0%, 1g

4,8-Dichloro-1,7-naphthyridine, 95.0%, 1g

2-(Bromomethyl)-4-chlorobenzonitrile, 95%, 1g

3,5-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 250mg

Ethyl 4-(3-methoxyphenyl)-3-oxobutanoate, 97%, 5g

2-(pyridin-4-yl)-1H-1,3-benzodiazole-4-carboxylic acid, 96%, 250mg

2-Bromo-1-(pyridin-2-yl)ethanone, 95.0%, 500mg